MOD GRF 1-29 is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2026-08-01. Where a claim depends on a specific study, the study is described rather than over-claimed.
Receptor level activity follows the canonical GHRH pathway. The peptide binds the GHRH receptor, a class B G protein coupled receptor on somatotroph cells of the anterior pituitary. Binding raises intracellular cyclic AMP, which promotes calcium entry and the release of growth hormone into the bloodstream. Because the molecule acts at the same receptor as the endogenous hormone, its effect is superimposed on the natural pulsatile rhythm rather than replacing it. Whether sustained receptor occupation leads to desensitization is not fully settled.
CJC-1295 belongs to a class of synthetic peptides modeled on growth hormone releasing hormone, a forty-four amino acid signal produced by the hypothalamus. The compound is built from the first twenty-nine residues of the natural sequence, with four substitutions introduced at positions 2, 8, 15 and 27. These changes were designed to slow enzymatic breakdown while preserving receptor activation. The result is a peptide that is shorter than native GHRH and considerably more resistant to ordinary clearance pathways in circulation.
Lyophilized peptide powder is comparatively stable when kept dry, cold, and protected from light. Once dissolved, the molecule is vulnerable to deamidation, oxidation, and aggregation, with the rate depending on pH, buffer composition, and temperature. Alkaline conditions and repeated freeze-thaw cycles accelerate loss of the intact peptide. The methionine present in the native sequence is a known oxidation site, which is one reason it was replaced in the modified fragment. Suppliers typically recommend cold storage of solutions and use within a short window.
Analytical confirmation usually relies on reversed-phase high-performance liquid chromatography for purity and on liquid chromatography coupled to mass spectrometry for identity. Mass data reveal the expected molecular mass and can flag truncated or oxidized species. Amino acid analysis and peptide mapping provide sequence-level verification. Immunoassays are used in some biological matrices, but antibodies raised against one releasing-hormone analog may cross-react with another. Reported purity figures depend heavily on the method used, so comparisons between suppliers require matching the analytical approach.
| Property | Value | Notes |
|---|---|---|
| Peptide class | Synthetic GHRH analogue | Built on a 29 residue sequence |
| Primary target | GHRH receptor (GHRHR) | Class B G protein coupled receptor |
| Unconjugated half life | Minutes | Limited by protease degradation |
| Key modification | Four residue substitutions | Positions 2, 8, 15 and 27 |
| Common synonym | Modified GRF(1-29) | Usually denotes the form without DAC |
CJC-1295 belongs to a family of synthetic peptides modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. The compound is built from the first twenty-nine amino acids of the natural human sequence, a fragment that retains full receptor binding capacity. Native growth hormone-releasing hormone is degraded quickly in circulation, so the fragment alone has limited practical value. Early work therefore focused on chemical modifications that preserve receptor binding while slowing enzymatic breakdown. The result is a molecule described in the literature as a long-acting analog of the natural hormone.
Two forms circulate under the CJC-1295 name, and they differ by a single appended group. The version without a drug affinity complex carries four substitutions along the peptide chain, including a D-alanine near the amino terminus and replacements at three other positions. These changes block the enzyme dipeptidyl peptidase IV and remove a methionine residue that is prone to oxidation. The modified fragment is frequently labeled MOD GRF 1-29. Naming conventions are inconsistent across informal sources, which is a common source of confusion.
Research material is normally supplied as a freeze-dried powder in sealed vials. In that state the peptide is comparatively robust, but prolonged exposure to warmth, moisture, or light accelerates degradation. Storage at minus twenty degrees Celsius or lower, with desiccant and protection from light, is the commonly described practice. Vials should be allowed to reach room temperature before opening to limit condensation on the powder. Moisture uptake during handling is a recognized source of variability in later measurements.
Reconstitution is typically performed with sterile water or bacteriostatic water, added slowly against the vial wall. The resulting solution should be clear and colorless; cloudiness or visible particles suggest a problem with the material or the diluent. Once in solution, the peptide is less stable than the dry powder. Refrigerated storage at two to eight degrees Celsius is common for short-term holding, while freezing aliquots is described for longer periods.
Binding to GHRH receptors on pituitary somatotroph cells triggers cyclic AMP signaling and stimulates growth hormone synthesis and release. Because the peptide acts upstream of the pituitary, effects are mediated through endogenous growth hormone rather than direct receptor activation in peripheral tissues. Increases in insulin-like growth factor 1 are generally described as a downstream consequence. Most published human exposure data come from small early-stage studies, and the clinical significance of the pharmacokinetic profile remains incompletely characterized.
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone, built on the 29-amino-acid GHRH(1-29) fragment. Four substitutions distinguish it from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes reduce enzymatic cleavage and extend the peptide's persistence in circulation. The compound is discussed in two forms, one carrying a drug affinity complex and one without it.
The peptide binds GHRH receptors on somatotroph cells within the anterior pituitary, triggering a signalling cascade that increases growth hormone secretion. Its improved resistance to dipeptidyl peptidase IV degradation distinguishes it from the parent hormone. In the DAC-bearing version, a maleimide group reacts with a cysteine residue on serum albumin, forming a covalent bond that keeps the peptide in circulation far longer. That albumin attachment is the central design feature separating the two research variants.
Pharmacokinetic behaviour differs sharply between the two forms. The DAC-bearing peptide shows an extended circulation time measured in days, whereas the version without the complex is cleared within roughly half an hour. This gap shapes how researchers design dosing schedules in animal models. Whether the prolonged presence of the DAC form produces effects meaningfully different from the short-acting variant remains an open question, since comparative human data are scarce.
== Spectroscopy == Both the fluorescence excitation and emission spectrums of wild-type EosFP are shifted ~65 nm to the right upon excitation toward the red end of the spectrum. This spectral change is caused by an extension of the chromophore accompanied by a break in the peptide backbone between Phe-61 and His-62 in an irreversible mechanism. The presence of a crisp isosbestic point at 432 nm also suggests an interconversion between two species. An absorption peak at 280 nm is visible due to aromatic amino acids which transfer their excitation energy to the green chromophore. The quantum yield of the green-emitting form of Eos is 0.7. In the red shifted species, there are pronounced vibronic sidebands separate from the main peak at 533 nm and 629 nm in the excitation spectrum and emission spectrum respectively. There is another peak in the red excitation spectrum at 502 nm likely due to FRET excitation of the red fluorophore. The quantum yield of the red-emitting form is 0.55. EosFPs variants show almost no difference in spectroscopic properties, therefore, it is likely that the structural modifications which arise from separation of interfaces have little to no effect on the structure of the fluorophore-binding site.
Thus, the 9s and 9p1/2 orbitals in essence replace the 8s and 8p1/2 ones, making elements 157–172 probably chemically analogous to groups 3–18: for example, element 164 would appear two places below lead in group 14 under the usual pattern, but is calculated to be very analogous to palladium in group 10 instead. Thus, it takes fifty-four elements rather than fifty to reach the next noble element after 118. However, while these conclusions about elements 157 through 172's chemistry are generally agreed by models, there is disagreement on whether the periodic table should be drawn to reflect chemical analogies, or if it should reflect likely formal electron configurations, which should be quite different from earlier periods and are not agreed between sources. Discussion about the format of the eighth row thus continues. Beyond element 172, calculation is complicated by the 1s electron energy level becoming imaginary. Such a situation does have a physical interpretation and does not in itself pose an electronic limit to the periodic table, but the correct way to incorporate such states into multi-electron calculations is still an open question, which would need to be answered to calculate the periodic table's structure beyond this point. Nuclear stability will likely prove a decisive factor constraining the number of possible elements. It depends on the balance between the electric repulsion between protons and the strong force binding protons and neutrons together.
When structures in different species are believed to exist and develop as a result of common, inherited genetic pathways, those structures are termed homologous. For example, the leaves of pine, oak, and cabbage all look very different, but share certain basic structures and arrangement of parts. The homology of leaves is an easy conclusion to make. The plant morphologist goes further, and discovers that the spines of cactus also share the same basic structure and development as leaves in other plants, and therefore cactus spines are homologous to leaves as well.
== Pathophysiology == The pathophysiology of LADA is similar to that of type 1 diabetes, in that it involves autoimmune destruction of pancreatic β-cells; however, this process occurs at a slower rate than in type 1 diabetes. This causes a gradual decline in insulin production; for a period individuals are not insulin-dependent. The immune-mediated destruction of β-cells varies in rate and extent among individuals, leading to different clinical courses.
Sources: en.wikipedia.org
In November 1993, sixteen months after Nickell's homicide, single mother Samantha Bisset and her four-year-old daughter Jazmine were murdered in their flat in Plumstead, London. The police detectives investigating the Bisset murders found the preponderance of similarities with the murder of Nickell very notable, and sat down to discuss this with the detectives from the Nickell murder. The Nickell detectives, who already had Stagg in custody at that time and thus had stopped looking for suspects, rejected – with "hostility" – the Bisset detectives' theory that the unknown murderer in the Bisset case was the true perpetrator in the Nickell case. The detective who later arrested Robert Napper for the Bisset murders also found the similarities convincing, and suggested Napper as a suspect in the murder of Rachel Nickell. In 1995, Napper was convicted for the Bisset murders. In July 2006, the Scotland Yard team interviewed him for two days at Broadmoor. Napper, 40 years old at that time, had been diagnosed as having paranoid schizophrenia and Asperger syndrome and had been held at the secure institution for more than ten years. On 28 November 2007, Napper was charged with Nickell's murder. He appeared at City of Westminster Magistrates' Court on 4 December 2007, where he was granted bail on condition he remained at Broadmoor psychiatric hospital until another hearing on 20 December 2007. On 24 January 2008, he pleaded not guilty to Nickell's murder and the trial started on 11 November 2008.
For the first time, clubs were allowed to trade future selections from the next year's draft as well as the current draft. Geelong became the first AFL club to trade a future draft pick on 14 October 2015 when they traded their 2016 first round pick to Carlton for Lachie Henderson.
5-HT2C receptor agonists are a class of drugs that activate 5-HT2C receptors. They have been investigated for the treatment of a number of conditions including obesity, psychiatric disorders, sexual dysfunction and urinary incontinence. The 5-HT2C receptors are one of three subtypes that belong to the serotonin 5-HT2 receptor subfamily along with 5-HT2A and 5-HT2B receptors. The development of 5-HT2C agonists has been a major obstacle, because of severe side effects due to a lack of selectivity. Activation of 5-HT2A receptors can induce hallucinations, and the activation of 5-HT2B receptors has been implicated in cardiac valvular insufficiency and possibly in pulmonary hypertension.
https://web.archive.org/web/20070405211049/http://www.dentistry.leeds.ac.uk/biochem/MBWeb/mb1/part2/krebs.htm#animat1 - animation of the general mechanism of the PDC (link on upper right) at University of Leeds Pyruvate+Dehydrogenase+Complex at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
Recent single-molecule tracking experiments in live E. coli showed an ongoing but slower protein synthesis upon treatment with different aminoglycoside drugs. (Spectinomycin, a related but distinct chemical structure class often discussed with aminoglycosides, does not induce mRNA misreading and is generally not bactericidal.)
Sources: en.wikipedia.org
==== Medication use ==== Most medications are compatible with continued breastfeeding. Many medicines pass into breastmilk in small amounts; however, very few medications actually reach the infant and are absorbed in a way that would actually impact the infant. Several characteristics of medications, including size and pH of the medication molecule and how well the medication is absorbed in the GI tract, influence how much of a medication may reach, and may ultimately be absorbed, by the infant. In addition to the effects on the infant, many medications are known to significantly suppress milk production, including pseudoephedrine, diuretics, and contraceptives that contain estrogen. There are several resources to assist medical professionals in determining which medications are safe for pregnancy and breastfeeding. While patients can use these resources, they are targeted toward medical professionals. Patients should be encouraged to consult a lactation specialist or a medical provider trained in breastfeeding medicine if any concerns arise. Two helpful resources are listed below.
The type of a mass spectrometer most widely used with MALDI is the time-of-flight mass spectrometer (TOF), mainly due to its large mass range. The TOF measurement procedure is also ideally suited to the MALDI ionization process since the pulsed laser takes individual 'shots' rather than working in continuous operation. MALDI-TOF instruments are often equipped with a reflectron (an "ion mirror") that reflects ions using an electric field. This increases the ion flight path, thereby increasing time of flight between ions of different m/z and increasing resolution. Modern commercial reflectron TOF instruments reach a resolving power m/Δm of 50,000 FWHM (full-width half-maximum, Δm defined as the peak width at 50% of peak height) or more. MALDI has been coupled with IMS-TOF MS to identify phosphorylated and non-phosphorylated peptides. MALDI-FT-ICR MS has been demonstrated to be a useful technique where high resolution MALDI-MS measurements are desired.
DNA can be twisted like a rope in a process called DNA supercoiling. With DNA in its "relaxed" state, a strand usually circles the axis of the double helix once every 10.4 base pairs, but if the DNA is twisted the strands become more tightly or more loosely wound. If the DNA is twisted in the direction of the helix, this is positive supercoiling, and the bases are held more tightly together. If they are twisted in the opposite direction, this is negative supercoiling, and the bases come apart more easily. In nature, most DNA has slight negative supercoiling that is introduced by enzymes called topoisomerases. These enzymes are also needed to relieve the twisting stresses introduced into DNA strands during processes such as transcription and DNA replication.
Designed for the Kill: The Jet Fighter—Development and Experience. United States Naval Institute, 1995, ISBN 0-87021-059-9. Stevenson, James. The Pentagon Paradox: The Development of the F-18 Hornet. Naval Institute Press, 1993, ISBN 1-55750-775-9. Tillman, Barrett. Hellcat Aces of World War 2. London: Osprey Aerospace, 1996. ISBN 1-85532-596-9. United States Air Force Museum Guidebook. Wright-Patterson AFB, Ohio: Air Force Museum Foundation, 1975. United States Army Air Force. AN 01-60JE-2: Maintenance and Erection Instructions for Army Model P-51D-5, −10, −15, 20, −25; P-51K-1, −5, −10, −15; British Model Mustang IV Aeroplanes. Evansville, Indiana: U.S.A.A.F, 1944. Wagner, Ray. American Combat Planes of the 20th Century. Reno, Nevada: Jack Bacon & Company, 2004. ISBN 978-0-930083-17-5. Wagner, Ray. Mustang Designer: Edgar Schmued and the P-51. Herndon, Virginia: Smithsonian Institution Press, 2000. ISBN 978-1-56098-994-3. Walker, Jeff. "Empire of the Sun." Air Classics, Volume 24, Number 1, January 1988. White, Graham. Allied Aircraft Piston Engines of World War II. Warrendale, Pennsylvania: Society for Automotive Engineers, 1995. ISBN 1-56091-655-9. Wilson, Stewart, ed. "Mustang Warbirds: Civil Registered Mustangs of Australia and New Zealand Then and Now." Warbirds of Australia and New Zealand 2010. St Leonards, New South Wales, Australia: Chevron Publishing Group, 2010. Wixey, Ken. "Magnificent Mustang: A Production History of the North American P-51." Air Enthusiast, Issue 95, September/October 2001. Yenne, Bill: Rockwell: The Heritage of North American.
Sources: en.wikipedia.org
The names are often used interchangeably in casual writing, but they are not strictly identical. Modified GRF(1-29) refers to the unconjugated analogue carrying only the four substitutions. The version sold as CJC-1295 with DAC includes the albumin binding linker and clears much more slowly.
DAC stands for drug affinity complex, a term describing the maleimidopropionic acid linker. This group forms a covalent bond with the cysteine residue on serum albumin after administration. The resulting adduct is what extends the circulating half life from minutes to days.
No. It is entirely synthetic and does not correspond to any known endogenous peptide. The design starts from human growth hormone releasing hormone and introduces deliberate substitutions. Any biological effect comes from mimicking the natural hormone at its receptor.
The version carrying the affinity complex bears a maleimide group that binds serum albumin, which extends its circulation time to several days. The version without it lacks this group and clears within roughly half an hour. The two are chemically related but behave very differently once in the body.